GlassScriptPhysician profile
Hanscy Seide
NPI 1194785519
$29,656.17
in general payments reported to CMS, 2019-2025
35 companies · $7,898 in 2025
The $7,898 reported for 2025 was more than what 75% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,135 · 2020: $552 · 2021: $3,199 · 2022: $2,321 · 2023: $4,959 · 2024: $2,592 · 2025: $7,898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,474 · Consulting Fee: $4,100 · Travel and Lodging: $1,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,474.34 |
| Consulting Fee | $4,100.00 |
| Travel and Lodging | $1,874.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $12,453.59 | 2019-2025 | Biomonitor |
| Medtronic, INC. | $6,250.00 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Linq II |
| Abbott Laboratories | $3,476.16 | 2019-2025 | Ensite Precision, Amplatzer Amulet, Ensite |
| Boston Scientific Corporation | $2,325.28 | 2019-2025 | Farapulse, Rhythmia Mapping System, Ingevity+ |
| Biosense Webster, INC. | $1,325.15 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Octaray Mapping Catheter |
| Cardiva Medical, INC. | $1,220.29 | 2019-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Medtronic Vascular, INC. | $309.79 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $255.67 | 2019-2025 | Lifevest |
| Acutus Medical, INC. | $187.31 | 2020-2021 | |
| Abiomed | $176.97 | 2022-2025 | Impella |
| Philips North America LLC | $169.91 | 2024-2025 | (Bk5) Azurion 5 M20, Igt Devices Undivided |
| Novartis Pharmaceuticals Corporation | $166.81 | 2019-2025 | |
| Cardiovascular Systems INC. | $146.84 | 2019-2023 | Diamondback Coronary |
| Elutia, INC. | $121.05 | 2019-2025 | Ecm Patch,Pouch |
| Impulse Dynamics (USA) INC. | $120.49 | 2023 | Optimizer |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $114.45 | 2019-2020 | |
| Cvrx, INC. | $114.29 | 2022-2024 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $83.45 | 2024-2025 | Assure Wcd |
| Atricure, INC. | $72.84 | 2024 | |
| Innovation Technologies INC | $72.66 | 2021 | |
| Irhythm Technologies, INC. | $69.88 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Cardiofocus, INC. | $48.64 | 2023 | Heartlight System |
| Cordis US Corp. | $47.82 | 2025 | Mynx Control Venous |
| Tactile Systems Technology INC | $36.79 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $34.93 | 2022-2024 | Eliquis |
| Inari Medical, INC. | $32.94 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $30.68 | 2019 | |
| Edwards Lifesciences Corporation | $29.95 | 2025 | Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $29.63 | 2019 | |
| Sanofi-Aventis U.S. LLC | $29.36 | 2023 | |
| Pfizer INC. | $26.39 | 2019-2024 | |
| Bardy Diagnostics, INC. | $25.50 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.29 | 2023 | Jardiance |
| Medicomp INC | $13.64 | 2019 | |
| Terumo Medical Corporation | $11.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hanscy Seide listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.